Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yuichi Ariyoshi

Feasibility of Neoadjuvant Ad-Reic Gene Therapy in Patients With High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Clinical and Translational Science

English

Related publications

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients With High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy

PLoS ONE

Multidisciplinary

2016

English

Does Diabetes Mellitus Increase the Risk of High-Grade Prostate Cancer in Patients Undergoing Radical Prostatectomy?

Prostate Cancer and Prostatic Diseases

English

Results of a Phase II Trial of Neoadjuvant Abiraterone + Prednisone+ Enzalutamide + Leuprolide (APEL) Versus Enzalutamide + Leuprolide (EL) for Patients With High-Risk Localized Prostate Cancer (PC) Undergoing Radical Prostatectomy (RP).

Journal of Clinical Oncology

English

Testosterone Replacement Therapy in Patients With Prostate Cancer After Radical Prostatectomy

Journal of Urology

Urology

2013

English

The Role of Radical Prostatectomy in the Treatment of Patients With High-Risk Prostate Cancer

Journal of Urological Surgery

2015

English

Oncological Results of Neoadjuvant Chemohormonal Therapy in Patients With High and Very High-Risk Prostate Cancer

English

Does Early Depressive Mood Expire Following Radical Retropubic Prostatectomy in Patients With Localized Prostate Cancer?

Journal of Exercise Rehabilitation

English

Golgi Phosphoprotein 3 Expression Predicts Poor Prognosis in Patients With Prostate Cancer Undergoing Radical Prostatectomy

Molecular Medicine Reports

English

Neoadjuvant and Adjuvant Chemohormonal Therapy in Patients With High-Risk and Very High-Risk Prostate Cancer: Our Experience

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yuichi Ariyoshi

Feasibility of Neoadjuvant Ad-Reic Gene Therapy in Patients With High-Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Related publications

Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients With High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy

Does Diabetes Mellitus Increase the Risk of High-Grade Prostate Cancer in Patients Undergoing Radical Prostatectomy?

Results of a Phase II Trial of Neoadjuvant Abiraterone + Prednisone+ Enzalutamide + Leuprolide (APEL) Versus Enzalutamide + Leuprolide (EL) for Patients With High-Risk Localized Prostate Cancer (PC) Undergoing Radical Prostatectomy (RP).

Testosterone Replacement Therapy in Patients With Prostate Cancer After Radical Prostatectomy

The Role of Radical Prostatectomy in the Treatment of Patients With High-Risk Prostate Cancer

Oncological Results of Neoadjuvant Chemohormonal Therapy in Patients With High and Very High-Risk Prostate Cancer

Does Early Depressive Mood Expire Following Radical Retropubic Prostatectomy in Patients With Localized Prostate Cancer?

Golgi Phosphoprotein 3 Expression Predicts Poor Prognosis in Patients With Prostate Cancer Undergoing Radical Prostatectomy

Neoadjuvant and Adjuvant Chemohormonal Therapy in Patients With High-Risk and Very High-Risk Prostate Cancer: Our Experience